PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Particle Accelerators”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 613 records · Page 34Linked to original sources
PubMed1998

Measurements of the neutron yields from 7Li(p,n)7Be reaction (thick target) with incident energies from 1.885 to 2.0 MeV.

Accelerator-based neutron source have been considered to be practical for boron neutron capture therapy (BNCT). Based on experience with a parameters of the Brookhaven National Laboratory BMRR reactor neutron source, which has been used in treatment experiments, the future accelerator-based neutron source for BNCT should have the properties of low energy distribution (< 100 keV) and high flux (about 10(9) neutrons per second per square centimeter) in the patient zone. Using protons to bombard thick 7Li targets, generating neutrons via the 7Li(p,n)7Be reaction, is one of the optimal choices for this kind of neutron source. Neutron yield data versus incident energy are necessary in order to select the proper incident energy and for estimating how high the incident proton current should be. The required proton beam current intensity is one of the key parameters for an accelerator useful for BNCT. In the present work, neutron yields of the 7Li(p,n)7Be reaction with a thick lithium target and incident energies of 1.885 and 1.9 MeV were measured at 0 degree with respect to the incident beam direction. The results are (3.08 +/- 0.17) x 10(12) and (5.71 +/- 0.32) x 10(12) neutrons/C sr, respectively. Neutron yield angular distribution measurements at 2 MeV incident energy were also performed. The proton beams were generated by the Peking University 4.5 MV electrostatic accelerator. The emitted neutrons from these reactions have the advantages of low energy distribution and forward angular distribution, which are requirements for a BNCT neutron source. The data obtained in this work can be used as a reference to study the accelerator-based neutron sources for BNCT.

Beryllium↗
PubMed1996

Short communication: a system for remote monitoring of a hospital linear accelerator.

Linear accelerators are complex machines with many parameters affecting the quality of the treatment beam delivered. A high level of technical support is required but this can be difficult to achieve if the linear accelerator is at a centre distant from a medical physics department. This paper describes a solution to this problem whereby a newly installed linear accelerator at the Royal Shrewsbury Hospital is remotely monitored from the Royal Hospital, Wolverhampton. The system enables run-up procedures to be completed by guiding radiographers at Shrewsbury through a series of steps. It consists of electronic hardware connected to the linear accelerator, under the control of a computer. The machine parameters are read and tested against preset tolerances. The monitoring system has been installed and is in routine use. The benefits have been shown to be: a saving in staff time and travel costs, the satisfactory completion of run-up procedures, a higher level of efficiency in the medical physics service provided and effective quality control. Finally, some future developments are presented. These include the development of a real time remote monitoring system that constantly monitors the linear accelerator, allowing the Medical Physics Department access to the machine parameters at any time.

Decision Making, Computer-Assisted↗
PubMedDate not supplied

[Technetium-99m production for use in nuclear medicine].

INTRODUCTION: Technetium-99m is the most important radioisotope used in nuclear medicine. Its routine application is ensured by introduction of 99Mo/99mTc generators. This paper reviews the present status and perspectives of different types of generators. Novelties in the production of either 99Mo for generators or directly 99mTc by using accelerators are also included. PRODUCTION OF 99MO IN NUCLEAR REACTORS AND 99MO/99MTC TYPES OF GENERATORS: The main source of 99Mo is a nuclear reactor. Nuclear reaction 99Mo(n, gamma)99Mo is rather simple, but the main disadvantage is a low specific activity of 99Mo. For routine production the nuclear reaction 235U(n,f)99Mo is used. It gives high yields of 99Mo of very high specific activity. However, its main disadvantages are high costs and generation of large quantities of highly radioactive waste. Depending on the separation method several types of generators were developed. The predominant is the chromatographic generator based on fission-produced 99Mo. Due to the disadvantages of (n,f)99Mo production, the alternatives based on (n, gamma)99Mo were developed. However, sublimation (except low temperature sublimation) and extraction generators at the present stage have no perspective. Only gel generators are promising. PRODUCTION OF 99MO AND 99MTC IN ACCELERATORS: Several nuclear reactions are considered. 100Mo(gamma, n)99Mo gives 99Mo of low specific activity. So it could be used in production by sublimation generators. The reaction 100Mo(p,pn)99Mo was also investigated but it seems not to be suitable for routine production of 99Mo. 99mTc can be directly produced by 98Mo(p, gamma)99mTc and 100Mo(p,2n)99mTc nuclear reactions. It seems that the latter could serve as an auxilliary source of 99mTc. CONCLUSION: At present chromatographic generators based on fission-produced 99Mo seem to have no real alternative. Gel and in lesser extent sublimation generators are prosperous, but still not suitable for large scale production of 99mTc. The accelerators offer good possibilities but a real alternative to fission 99Mo has not been found yet.

Molybdenum↗
PubMed1983

[Dosimetric characteristics of the bremsstrahlung beam from the LUE-15M medical linear electron accelerator].

The paper presents methods and results of a study of radiation-physical characteristics of inhibitory radiation beam with the Grenz energy of 15MeV generated by an electron linear accelerator LUE-15M. Special emphasis is laid on primary dosimetric information used for the planning of radiotherapy: depth doses, beam profiles, dose functions of a collimated beam. It has been shown that in general the accelerator meets the requirements of the International Electrotechnical Commission. General error in the focal absorbed dose at the expense of variable parameters of the accelerator was evaluated. It does not exceed +/- 3.5%.

Particle Accelerators↗
PubMed1988

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol.

The effects of probucol (500 mg twice daily) on high-density lipoprotein (HDL) subfractions and cholesteryl ester transfer from HDL to lower density lipoproteins were tested in a series of patients with Type II hypercholesterolemia. In this placebo-controlled crossover trial, patients received probucol or placebo for 8 weeks, then switched to the other agent for another 8 weeks. Probucol significantly lowered total, low-density lipoprotein and HDL cholesterol levels. HDL subfractions, separated by rate zonal ultracentrifugation, showed a dramatic reduction in HDL2, whereas changes in HDL3 were not significant. Both subfractions eluted at a characteristically lower volume, indicating a reduced flotation rate. These findings were confirmed by gradient gel electrophoretic separation, which showed a typical reduction or disappearance of HDL2b particles and the prevalence of particles in the HDL3a-HDL3b electrophoretic range in almost all patients. After treatment, cholesteryl ester transfer from HDL to lower density lipoproteins was significantly increased in all patients. These data suggest that probucol may accelerate HDL particle conversion, leading to improvement in reverse cholesterol transport from the periphery to the liver, through HDL and very low density lipoprotein.

Carrier Proteins↗
PubMed2006

Laser acceleration of quasi-monoenergetic MeV ion beams.

Acceleration of particles by intense laser-plasma interactions represents a rapidly evolving field of interest, as highlighted by the recent demonstration of laser-driven relativistic beams of monoenergetic electrons. Ultrahigh-intensity lasers can produce accelerating fields of 10 TV m(-1) (1 TV = 10(12) V), surpassing those in conventional accelerators by six orders of magnitude. Laser-driven ions with energies of several MeV per nucleon have also been produced. Such ion beams exhibit unprecedented characteristics--short pulse lengths, high currents and low transverse emittance--but their exponential energy spectra have almost 100% energy spread. This large energy spread, which is a consequence of the experimental conditions used to date, remains the biggest impediment to the wider use of this technology. Here we report the production of quasi-monoenergetic laser-driven C5+ ions with a vastly reduced energy spread of 17%. The ions have a mean energy of 3 MeV per nucleon (full-width at half-maximum approximately 0.5 MeV per nucleon) and a longitudinal emittance of less than 2 x 10(-6) eV s for pulse durations shorter than 1 ps. Such laser-driven, high-current, quasi-monoenergetic ion sources may enable significant advances in the development of compact MeV ion accelerators, new diagnostics, medical physics, inertial confinement fusion and fast ignition.

Journal Article↗
PubMed1990

Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula.

Radiosurgery techniques permit high doses of single fraction irradiation to be administered to small volumes of tumor with relative sparing of surrounding brain tissue. The tolerance of surrounding normal brain tissue to dose distributions from linear accelerator radiosurgery with different collimator sizes is an important factor that must be estimated by anyone using these treatment techniques. The exponential and linear quadratic versions of the integrated logistic formula were used to estimate the probability of brain necrosis at different doses for radiosurgical dose distributions administered by a 6 MV linear accelerator with a 5 arc technique for collimator sizes from 12.5 to 30 mm in diameter. Dose-volume isoeffect curves for a 3% risk of brain necrosis from linear accelerator radiosurgery were then calculated. These curves approximate those calculated for gamma knife radiosurgery and a published 1% dose-volume isoeffect line predicted for proton beam irradiation. Similar dose-volume isoeffect curves were calculated for single fraction radiosurgery boosts administered after 30 Gy of whole brain irradiation in 12 fractions. The integrated logistic formula appears to be a useful tool for estimating tolerance and providing guidelines for prescribing radiation doses for linear accelerator radiosurgery.

Brain Diseases↗
PubMed2001

[Pin-hole camera studies of the head scatter contribution and the photon source size of a linear accelerator].

There are different opinions of the jaws scatter contribution to the photon fluence of medical linear accelerators. Investigations were performed at the Radiology Clinic of the University of Jena to give an experimental answer to this question. Since the study object was the linear accelerator LUE, now out of operation, the method of investigation is was the topic of this report. By use of a pin-hole camera and a "beam stopper", the focal and extrafocal radiation was projected upon the image plane of the camera and was measured with films or a Schuster detector array. The following relative contributions of the particular source regions to the total photon fluence in the field center were obtained: flattening filter (91.8 +/- 1)%, primary collimator (7.2 +/- 0.9)%, collimator jaws (1.0 +/- 0.3)%. These results are in good agreement with those of Ahnesjö. For this accelerator, the 37% width of the photon source region is (20 +/- 1) mm.

Head↗
PubMed2003

Which accelerator photon beams are "clinic-like" for reference dosimetry purposes?

Previous work has demonstrated that, for photon beam dosimetry, TPR10(20) is not an ideal beam quality specifier for all bremsstrahlung beams, especially for lightly filtered beams in some standards laboratories. This paper addresses the following questions: Is TPR10(20) an adequate beam quality specifier for all modern clinical therapy accelerators? When can nonclinical beams in standards laboratories be used to calibrate ion chambers or measure kQ factors as a function of TPR10(20)? Based on detailed Monte Carlo simulations of Varian, Siemens, Elekta, and GE (Saturn) accelerators one can conclude that TPR10(20) is an adequate beam quality specifier for all these machines in the sense that for a given value of TPR10(20), the value of stopping-power ratios is the same. It is shown that, for the heavily filtered beams used in standards laboratories, TPR10(20) is an adequate beam quality specifier. It is also demonstrated that, for a larger range of bremsstrahlung beams than previously, %dd(10)x is a good beam quality specifier for all clinical beams as well as the lightly and heavily filtered beams in some standards laboratories. A criterion, based on the measured values of TPR10(20) and %dd(10)x for the beam, is proposed for determining whether a nonclinical beam is well specified by TPR10(20). Agreement between calculations for specific accelerators and measured beam quality specifiers is shown to be good, but agreement with published data for a variety of clinical accelerators is not as good. Possible reasons for the discrepancy are discussed.

Energy Transfer↗
PubMed2006

Measurements of in-air output ratios for a linear accelerator with and without the flattening filter.

The in-air output ratio (Sc) for photon beams from linear accelerators describes the change of in-air output as a function of the collimator settings. The physical origin of the Sc is mainly due to the change in scattered radiation that can reach the point of measurement as the geometry of the head changes. The flattening filter (FF) and primary collimator are the major sources of scattered radiation. The change in amount of backscattered radiation from the collimator into the beam-monitoring chamber also contributes to the variation of output. In this work, we measured the Sc and backscatter factors (Sb) into the beam-monitoring chamber for a linear accelerator with and without the FF. We measured the Sc with a Farmer-type chamber in a miniphantom at the depth of 10 g/cm2 for 6- and 18-MV x-ray beams from a Varian Clinac 2100EX linear accelerator. The Sb were measured with a universal pulse counter and a diode array with build-in counting hardware and software. The head scatter component (Sh) was then derived from the relationship Sc= Sh x Sb, where Sb was the linear fit of measured results. Significant differences were observed for Sc with and without the FF. Within the range of experimental uncertainty, the Sb was similar with and without the FF. The variations in Sh differed significantly over the range of field sizes of 3 X 3 to 40 X 40 cm2 with and without the FF; for the 6-MV beam, it was 8% vs 3%, and for the 18-MV beam, 7% vs 1%. By analyzing the contributions of backscatter factor and total in-air output ratios with and without the FF, we directly gained insight into the contributions of different components to the total variations in Sc of a linear accelerator. Sc, Sb, and Sh are basic and useful dosimetric quantities for delivery of intensity-modulated radiation therapy using a linear accelerator operating in a mode without the FF.

Air↗
PubMed1998

A generic off-axis energy correction for linac photon beam dosimetry.

Cooperative clinical trial group protocols frequently require off-axis point dose calculations. The Radiological Physics Center uses the calculative technique developed by Hanson et al. [Med. Phys. 7, 145-146 (1980); 7, 147-150 (1980)] to verify these calculations. In order to correct for off-axis energy changes, this technique requires off-axis half-value layer data, HVL, as a function of off-axis ray angle for the specific beam. This paper presents a formulism based on HVL mesurements on a limited number of therapy beams, which allows the calculation of an off-axis energy-correction factor for any clinical photon beam created by a linear accelerator using conventional flattening filters.

Clinical Protocols↗
PubMed1995

[Stereotactic radiation therapy with linear accelerator: accuracy of alignment and portal film verification].

Stereotactic radiation therapy with a linear accelerator requires precise alignment of therapeutic radiation distribution to the target volume. To verify the accuracy of alignment, differences between the stereotactic coordinates of the center of the therapeutic radiation distribution determined from portal films and those of the target points determined from CT/MRI or CT/angiographic localization were calculated for 58 points. The average values and one standard deviation were--0.02 +/- 0.50mm, 0.37 +/- 0.39mm and 0.01 +/- 0.25mm in the x, y, and z directions, respectively. The average value of the total deviation was 0.73 +/- 0.07mm. Potential sources of misalignment were misaligned laser pointers, wide laser beam width, improperly zeroed target positioner scale, and motion of the patient couch. The accuracy of alignment should be verified prior to irradiation. Portal film verification is indispensable for strereotactic radiation therapy with a linear accelerator.

Cranial Irradiation↗
PubMed1979

Neutron dosimetry in high energy X-ray beams of medical accelerators.

High energy X-ray beams from medical accelerators are used in cancer therapy. In such beams, neutrons are also produced due to photon-neutron interactions in the target material, collimator and beam flattening filter. The feasibility of employing fast-neutron-induced recoil particle tracks in polycarbonate foils developed by the electrochemical etching (ECE) method for the dosimetry of such neutrons was investigated. The experiments were carried out in, and out of, the beam of a Varian Clinac-18, an Allis-Chalmers 25 MeV betatron and a Brown Boveri 45 MeV betatron. Neutron dose equivalents were found both as a function of the photon dose and of the distance away from the centre of the beam. The neutron dose equivalent was found to be 0.6 and 1.3% of the X-ray dose at the centre position of the beam for a TSD = 100 cm and a 10 x 10 cm2 field for the 25 and 45 MeV betatrons respectively. Although the dosemeter showed adequate sensitivity to neutrons in the beam of the betatrons, it showed insensitivity to neutrons in the beam of the Clinac-18 which has a softer spectrum than the neutron energy threshold of the dosemeter. It can be concluded that this dosimetry method provides a new approach with a number of advantages compared to some other existing techniques for such measurements above the energy threshold of the dosemeter.

Neutrons↗